Atropine and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Atropine
Buprenorphine
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines can slow down your gut and your bladder. Atropine is a drug that dries up secretions and relaxes muscles, and it naturally slows how fast your intestines move. Buprenorphine is an opioid-type medicine that also causes constipation. When you take them together, those effects can add up.
In rare cases, the gut can slow so much that it nearly stops moving. This is called paralytic ileus. You could also have trouble emptying your bladder. The good news is this concern is mostly theoretical, and your care team can watch for it. Please don't stop either medicine on your own. Just call your pharmacist or doctor with any questions.
Effect: Additive anticholinergic and opioid effects on GI motility may increase the risk of severe constipation, urinary retention, and paralytic ileus.
- Mechanism: Additive reduction in gastric/intestinal motility (atropine's antimuscarinic action plus buprenorphine's opioid effect on gut). PD interaction; neither agent's activation depends on the other.
- Direction: Increased anticholinergic/constipating burden.
- Evidence: Theoretical; severity rated major. Onset unspecified.
- Management: Monitor for reduced bowel sounds, abdominal distension, constipation, and urinary retention. Ensure adequate bowel regimen; individualize dosing and consider alternatives if symptoms emerge.
What happens
An increased risk of paralytic ileus
Interaction Deep Dive
Using buprenorphine together with an anticholinergic drug can lead to urinary retention or severe constipation that progresses to paralytic ileus. When these agents are given concurrently, watch patients for indications of urinary retention or decreased gastric motility1.
Why it happens (mechanism)
Additive effects on gastric motility
How to manage this interaction
Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. This interaction is usually manageable.
- Your team may monitor you more closely for constipation, a bloated or hard belly, no bowel movements, nausea, or trouble urinating.
- Doses may need to be adjusted and individualized by your care team, and a bowel routine (fluids, fiber, or a stool softener your provider recommends) may help.
- Call your pharmacist or prescriber right away if you notice severe constipation, belly swelling, vomiting, or difficulty passing urine.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Atropine and Buprenorphine together?
Taking atropine with buprenorphine can add up to cause severe constipation or urinary retention, so watch for a bloated belly, no bowel movements, or trouble urinating and report these to your care team while continuing both as prescribed. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Atropine and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Atropine and Buprenorphine interaction managed?
Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. This interaction is usually manageable. Your team may monitor you more closely for constipation, a bloated or hard belly, no bowel movements, nausea, or trouble urinating. Doses may need to be adjusted and individualized by your care team, and a bowel routine (fluids, fiber, or a stool softener your provide… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Atropine or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
Keep reading about Atropine
Keep reading about Buprenorphine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist